Nurix Therapeutics Inc’s filing revealed that its Chief Legal Officer Ring Christine unloaded Company’s shares for reported $0.11 million on Jan 31 ’25. In the deal valued at $19.95 per share,5,760 shares were sold. As a result of this transaction, Ring Christine now holds 32,538 shares worth roughly $0.55 million.
Then, CHRISTINE RING bought 5,760 shares, generating $115,286 in total proceeds.
Before that, Ring Christine sold 3,220 shares. Nurix Therapeutics Inc shares valued at $63,929 were divested by the Chief Legal Officer at a price of $19.85 per share. As a result of the transaction, Ring Christine now holds 32,538 shares, worth roughly $0.55 million.
BTIG Research initiated its Nurix Therapeutics Inc [NRIX] rating to a Buy in a research note published on December 10, 2024; the price target was $35. A number of analysts have revised their coverage, including BMO Capital Markets’s analysts, who began to cover the stock in early December with a ‘”an Outperform”‘ rating. UBS began covering NRIX with “Buy” recommendation on October 24, 2024. Jefferies started covering the stock on October 11, 2024. It rated NRIX as “a Buy”.
Price Performance Review of NRIX
On Friday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock fall -0.06% to $16.86. Over the last five days, the stock has lost -4.15%. Nurix Therapeutics Inc shares have fallen nearly -10.51% since the year began. Nevertheless, the stocks have risen 67.93% over the past one year. While a 52-week high of $29.56 was reached on 01/27/25, a 52-week low of $9.91 was recorded on 02/24/25. SMA at 50 days reached $19.18, while 200 days put it at $20.93.
Levels Of Support And Resistance For NRIX Stock
The 24-hour chart illustrates a support level at 16.43, which if violated will result in even more drops to 15.99. On the upside, there is a resistance level at 17.25. A further resistance level may holdings at 17.63. The Relative Strength Index (RSI) on the 14-day chart is 35.86, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.80, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.14%. Stochastics %K at 12.33% indicates the stock is a buying.
